Showing results (191-200 of 2,746) with videos related to

Sort By:
Pageof 275
Clinical and Experimental Nephrology|October 14, 2017
Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunctionAya Imafuku, Naoki Sawa, Akinari Sekine, et al.
Clinical and Experimental Nephrology|March 31, 2018
Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional studyTeppei Okamoto, Shingo Hatakeyama, Yoshimi Tanaka, et al.
Clinical and Experimental Nephrology|November 29, 2017
Decrease in toe pinch force in male type 2 diabetic patients with diabetic nephropathyHiroaki Kataoka, Nobuyuki Miyatake, Naomi Kitayama, et al.
Clinical and Experimental Nephrology|December 4, 2018
Peritoneal protein clearance predicts mortality in peritoneal dialysis patientsWanhong Lu, Wing-Fai Pang, Li Jin, et al.
Clinical and Experimental Nephrology|March 23, 2018
Clinico-pathological features of kidney disease in diabetic casesKengo Furuichi, Miho Shimizu, Hirokazu Okada, et al.
Clinical and Experimental Nephrology|December 26, 2018
Pair analysis and custom array CGH can detect a small copy number variation in COQ6 geneKeita Nakanishi, Takayuki Okamoto, Kandai Nozu, et al.
Clinical and Experimental Nephrology|November 28, 2018
Protection of the kidney with sodium-glucose cotransporter 2 inhibitors: potential mechanisms raised by the large-scaled randomized control trialsSatoru Kuriyama
Clinical and Experimental Nephrology|November 23, 2019
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 studyTatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, et al.
Clinical and Experimental Nephrology|November 23, 2019
Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemiaSatoru Kuriyama
Clinical and Experimental Nephrology|November 25, 2019
Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairmentYuji Kumagai, Masashi Sakaki, Kenichi Furihata, et al.
Pageof 275